J.M. Brogard
Impact in
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Drug-Induced Hepatotoxicity and Protection
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 35
- Antibiotics Pharmacokinetics and Efficacy 34
- Oncology 27
- Drug Transport and Resistance Mechanisms 25
- Co-authors
- Jean-Frédéric Westphal (8 shared papers)D Vetter (1 shared paper)F. Jehl (11 shared papers)H. Monteil (10 shared papers)Jean‐Frédéric Blickle (14 shared papers)M Adloff (10 shared papers)M. Pinget (18 shared papers)J.P. Arnaud (10 shared papers)
In The Last Decade
J.M. Brogard
58 papers receiving 594 citations
Peers
Comparison fields: 5 of 94
- Pharmacology 264
- Molecular Medicine 80
- Applied Microbiology and Biotechnology 19
- Pharmacology 67
- Oncology 118
Countries citing papers authored by J.M. Brogard
This map shows the geographic impact of J.M. Brogard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Brogard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Brogard more than expected).
Fields of papers citing papers by J.M. Brogard
This network shows the impact of papers produced by J.M. Brogard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Brogard. The network helps show where J.M. Brogard may publish in the future.
Co-authors
The 25 scholars most cited alongside J.M. Brogard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 141 | |
| 2 | 1985 | 50 | |
| 3 | 1997 | 41 | |
| 4 | 1985 | 39 | |
| 5 | Retrospective monocentric study of 17 patients with adult Still's disease, with special focus on liver abnormalities. | 2003 | 34 |
| 6 | High biliary elimination of ceftriaxone in man. | 1988 | 27 |
| 7 | 1980 | 23 | |
| 8 | 1991 | 22 | |
| 9 | 1991 | 17 | |
| 10 | 1989 | 15 | |
| 11 | 1973 | 15 | |
| 12 | 1987 | 14 | |
| 13 | 1977 | 14 | |
| 14 | 1989 | 13 | |
| 15 | 1975 | 12 | |
| 16 | 1999 | 10 | |
| 17 | 1988 | 10 | |
| 18 | Glycated immunoglobulin M in diabetic patients. | 1993 | 10 |
| 19 | 1975 | 10 | |
| 20 | 1976 | 9 |
About J.M. Brogard
J.M. Brogard is a scholar working on Pharmacology, Oncology, Molecular Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, having authored 63 papers that have together received 643 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (34 papers), Drug Transport and Resistance Mechanisms (25 papers), Antibiotic Resistance in Bacteria (15 papers), Gallbladder and Bile Duct Disorders (12 papers), Pharmacological Effects and Toxicity Studies (8 papers), Diabetes Management and Research (7 papers), Diabetes Treatment and Management (5 papers) and Pediatric Hepatobiliary Diseases and Treatments (5 papers). The work is most often cited by research in Pharmacology (264 citations), Molecular Medicine (80 citations), Applied Microbiology and Biotechnology (19 citations), Pharmacology (67 citations) and Oncology (118 citations). J.M. Brogard has collaborated with scholars based in France, Slovakia and Japan. Frequent co-authors include Jean-Frédéric Westphal, D Vetter, F. Jehl, H. Monteil, Jean‐Frédéric Blickle, M Adloff, M. Pinget, J.P. Arnaud, J F Blicklé and R Minck. Their work appears in journals such as Chemotherapy, Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, The Journal of Clinical Pharmacology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.